← New search
Phenotype profile

familial hypercholesterolemia

HP:0003124 · 143890 · SaudiVarKB evidence summary derived from retained literature mentions.

155Phenotype mentions
100Publications
50Associated gene records
50Associated variant records

Associated gene records

Co-mentioned in the same publications
GeneIdentifier / contextArticlesMentions
LDLRHGNC:65474040
PCSK9HGNC:200012525
APOBHGNC:6031010
ABCG5HGNC:1388633
PAHHGNC:858222
APOEHGNC:61322
SCN5AHGNC:1059322
ACEHGNC:270722
CYP3A5HGNC:263822
LDLRAP1HGNC:1864022
PON1HGNC:920422
CYP7A1HGNC:265122
CD4HGNC:167811
ENPP1HGNC:335611
CD40HGNC:1191911
TBX4HGNC:1160311
SCN10AHGNC:1058211
TGHGNC:1176411
KCNQ1HGNC:629411
G6PDHGNC:405711
STAT3HGNC:1136411
PMP22HGNC:911811
AGLHGNC:32111
PLCG2HGNC:906611
ABCB1HGNC:4011
CYP3A4HGNC:263711
BRAFHGNC:109711
GATA2HGNC:417111
VDRHGNC:1267911
ASPMHGNC:1904811
ANGPTL3HGNC:49111
JAK2HGNC:619211
ATP8B1HGNC:370611
ABCG8HGNC:1388711
AKAP9HGNC:37911
EGFRHGNC:323611
CSNK1A1HGNC:245111
JAK3HGNC:619311
RALAHGNC:983911
ZEB2HGNC:1488111
EGFHGNC:322911
ABCA1HGNC:2911
FASHGNC:1192011
MPLHGNC:721711
GRM7HGNC:459911
CD44HGNC:168111
PRDM13HGNC:1399811
JAK1HGNC:619011
TDP1HGNC:1888411
CHD7HGNC:2062611

Associated variant records

Co-mentioned in the same publications
VariantIdentifier / contextArticlesMentions
p.W577Cp.W577C33
c.1474G>Ac.1474G>A22
p.D492Np.D492N22
c.1429G>Ac.1429G>A22
p.D477Np.D477N22
c.2027delGc.2027delG22
c.2027delc.2027del11
p.C231*p.C231*11
p.R744*p.R744*11
c.335_336insCGAGc.335_336insCGAG11
p.F114Rfsp.F114Rfs11
c.622G>Ac.622G>A11
p.E208Kp.E208K11
c.1421C>Gc.1421C>G11
p.S474*p.S474*11
p.His493Argp.His493Arg11
rs151009667rs15100966711
p.Y419Dp.Y419D11
p.S202Tfsp.S202Tfs11
rs429358rs42935811
rs7412rs741211
p.Arg987Terp.Arg987Ter11
p.Asp36Tyrp.Asp36Tyr11
p.Gly140Serp.Gly140Ser11
p.Arg284Terp.Arg284Ter11
p.Pro106Leup.Pro106Leu11
Q192RQ192R11
p.Trp577Argp.Trp577Arg11
p.Leu479Glnp.Leu479Gln11
p.Glu668*p.Glu668*11
c.1731G>Tc.1731G>T11
c.1783C>Tc.1783C>T11
p.R595Wp.R595W11
c.9835A>Gc.9835A>G11
p.S3279Gp.S3279G11
G894TG894T11
p.G676Afsp.G676Afs11
c.2026delGc.2026delG11
1171G>A1171G>A11
1167G>A1167G>A11
c.1706-1715delc.1706-1715del11
c.2416dupc.2416dup11
p.Gln35Terp.Gln35Ter11
c.2416dupGc.2416dupG11
rs2278426rs227842611
c.666_670dupc.666_670dup11
p.Ser3279Glyp.Ser3279Gly11
R496WR496W11
rs629301rs62930111
rs1367117rs136711711

Associated population records

Co-mentioned in the same publications
PopulationIdentifier / contextArticlesMentions
Saudi Arabia1818
Saudi Arabia55
Population record55
Population recordCohort 1633
Population recordCohort 322
Saudi Arabia · Riyadh22
Population recordCohort 2822
Population recordCohort 20022
Saudi ArabiaCohort 20022
Population recordCohort 95011
Population recordCohort 1911
Population recordCohort 91211
Saudi ArabiaCohort 3711
Population recordCohort 411
Saudi Arabia · JazanCohort 12311
Saudi ArabiaCohort 8811
Population recordCohort 5011
Saudi ArabiaCohort 51411
Saudi Arabia · Jeddah11
Population recordCohort 54011
Population recordCohort 19611
Saudi Arabia · RiyadhCohort 10011
Saudi ArabiaCohort 4311
Population recordCohort 3211
Saudi Arabia · HailCohort 43011
Saudi Arabia · Asir11
Saudi ArabiaCohort 12011
Saudi ArabiaCohort 10011
Population recordCohort 911
Saudi Arabia · HailCohort 111
Saudi Arabia · Qassim11
Saudi ArabiaCohort 50011
Saudi Arabia · Jazan11
Population recordCohort 61211
Saudi ArabiaCohort 36611
Saudi ArabiaCohort 2211
Population recordCohort 7911
Saudi Arabia · Hail11
Population recordCohort 75111
Population recordCohort 1,25711
Saudi ArabiaCohort 13911
Population recordCohort 8811
Saudi ArabiaCohort 911
Saudi ArabiaCohort 12811
Population recordCohort 21511
Saudi Arabia · RiyadhCohort 22511
Saudi Arabia · RiyadhCohort 1711
Saudi ArabiaCohort 9211
Saudi ArabiaCohort 25011
Saudi Arabia · RiyadhCohort 49211

Supporting publications

100 records
  1. 2026Optimizing cardiovascular health: a systematic review and meta-analysis of olezarsen dosages in high-risk hypertriglyceridemic patients.Naunyn-Schmiedeberg's archives of pharmacologyPubMed ↗
  2. 2026Whole-exome sequencing in obstructive coronary artery disease identifies rare and novel variants in cardiac arrhythmia and pulmonary arterial hypertension-associated genes.Biomolecules & biomedicinePubMed ↗
  3. 2026Severe left main and ostial right coronary obstruction with supra aortic valve atherosclerotic stenosis in a 16 Year old patient with familial hypercholesterolemia: A case report.Journal of cardiovascular computed tomographyPubMed ↗
  4. 2026Traditional cardiovascular risk factors and their association with atherosclerotic cardiovascular disease in homozygous familial hypercholesterolemia: A cross-sectional analysis from the HICC registry.AtherosclerosisPubMed ↗
  5. 2026Global survey of genetic testing methods for familial hypercholesterolemia. A study and recommendations from the EAS FHSC registry.European journal of preventive cardiologyPubMed ↗
  6. 2026Homozygous familial hypercholesterolaemia: insights from the Global HICC Registry.European heart journalPubMed ↗
  7. 2026Investigating the phytotherapeutic efficacy of Acacia nilotica pod ethanolic extract in modulating lipid profile, oxidative stress and inflammation in diet-induced hypercholesterolemia: in vivo and in silico insights.Frontiers in pharmacologyPubMed ↗
  8. 2026Correction: Untargeted metabolomics reveals distinct biomarkers and metabolic alterations in familial and non-genetic hypercholesterolemia in Saudi patients.Frontiers in medicinePubMed ↗
  9. 2026Meta-Analysis of Oral PCSK9 Inhibitors for Hypercholesterolemia in Adults: A Systematic Review and GRADE Assessment.Cardiology in reviewPubMed ↗
  10. 2026Advancing Lipid Management: Saudi Heart Association Position Statement on PCSK9-targeted Therapies in the Primary and Secondary Prevention of Cardiovascular Disease.Journal of the Saudi Heart AssociationPubMed ↗
  11. 2026Premature atherosclerotic cardiovascular disease in the MENA region: economic impact, barriers to care, and policy recommendations for an escalating crisis.Current opinion in lipidologyPubMed ↗
  12. 2025Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry.European heart journalPubMed ↗
  13. 2025Unraveling molecular interconnections and identifying potential therapeutic targets of significance in obesity-cancer link.Journal of the National Cancer CenterPubMed ↗
  14. 2025Familial hypercholesterolemia in pregnancy.Current opinion in lipidologyPubMed ↗
  15. 2025Homozygous familial hypercholesterolemia evaluation and survival single center study in Saudi Arabia: The HESSA registry.AtherosclerosisPubMed ↗
  16. 2025Homozygous Familial Hypercholesterolemia Is a Life-Limiting Condition: Medical Life-Trajectories in the Post-2010 Era.Journal of the American College of CardiologyPubMed ↗
  17. 2025Long noncoding RNAs in familial hypercholesterolemia: biomarkers, therapeutics, and AI in precision medicine.Lipids in health and diseasePubMed ↗
  18. 2025The Prevalence and Predictors of Sickle Cell Anemia in the Saudi Arabia General Population: Findings from a Cross-Sectional Study.Healthcare (Basel, Switzerland)PubMed ↗
  19. 2025Prevalence of very high cholesterol levels in asymptomatic military recruits: A single center study.Saudi medical journalPubMed ↗
  20. 2025Unlocking the potential: advancements and applications of gene therapy in severe disorders.Annals of medicinePubMed ↗
  21. 2025Homozygous familial hypercholesterolemia in a high-consanguinity population: Insights from a Saudi cohort.Journal of clinical lipidologyPubMed ↗
  22. 2025Gastric mucosal differentially expressed genes after bariatric surgery: Effects on sterol-related pathways.The Journal of steroid biochemistry and molecular biologyPubMed ↗
  23. 2025Assessment of Primary Health Care Physicians' Awareness, Knowledge, and Practice of Familial Hypercholesterolemia in Jazan, Saudi Arabia.CureusPubMed ↗
  24. 2025Multimodal Therapy Achieves Secondary Prevention LDL-C Targets in LDL-Receptor Null Homozygous Familial Hypercholesterolemia.JACC. Case reportsPubMed ↗
  25. 2025Pathogenic LDLR Variants (c.103 C>T and c.2416dup) in ligand-binding and cytosolic domains in Saudi familial hypercholesterolemia: Molecular characterization and computational insights.Computational and structural biotechnology journalPubMed ↗
  26. 2025Flaxseed in Diabetes Management: Nutritional and Therapeutic Insights.Current nutrition reportsPubMed ↗
  27. 2025Untargeted metabolomics reveals distinct biomarkers and metabolic alterations in familial and non-genetic hypercholesterolemia in Saudi patients.Frontiers in medicinePubMed ↗
  28. 2025Medical and Financial Consequences of Using PCSK9 Inhibitors for Managing Hypercholesterolemia in Saudi Arabia: A Historical Cohort Study.Healthcare (Basel, Switzerland)PubMed ↗
  29. 2025Whole exome sequencing identifies concurrent LDLR and ABCG8 mutations in a Saudi family with familial hypercholesterolemia and Sitosterolaemia.Frontiers in geneticsPubMed ↗
  30. 2025Fair pricing, fair access; a systematic review of cost-effectiveness of new hyperlipidemia injectable medication in developing countries.Cost effectiveness and resource allocation : C/EPubMed ↗
  31. 2024Modern approaches to the management of homozygous familial hypercholesterolemia in the Middle East and North Africa.Journal of clinical lipidologyPubMed ↗
  32. 2024The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis.Advances in therapyPubMed ↗
  33. 2024Knowledge, attitude, and practice of physicians towards familial hypercholesterolaemia in north regions of Saudi Arabia.JPMA. The Journal of the Pakistan Medical AssociationPubMed ↗
  34. 2024Berberine attenuates inflammation and oxidative stress and modulates lymphocyte E-NTPDase in acute hyperlipidemia.Drug development researchPubMed ↗
  35. 2024Correction to: The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis.Advances in therapyPubMed ↗
  36. 2024Addressing comprehensive complexities a striking familial hypercholesterolemia case study.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of CardiologyPubMed ↗
  37. 2024Association between genetic variants of GRM7 (rs1396409 and rs9883258) and treatment outcomes in Schizophrenic Egyptian patients.Nucleosides, nucleotides & nucleic acidsPubMed ↗
  38. 2024Lomitapide: A Medication Use Evaluation and a Formulary Perspective.Global journal on quality and safety in healthcarePubMed ↗
  39. 2024Potentials of artificial intelligence in familial hypercholesterolemia: Advances in screening, diagnosis, and risk stratification for early intervention and treatment.International journal of cardiologyPubMed ↗
  40. 2024Sucralose Influences the Productive Performance, Carcass Traits, Blood Components, and Gut Microflora Using 16S rRNA Sequencing of Growing APRI-Line Rabbits.Animals : an open access journal from MDPIPubMed ↗
  41. 2024Sitosterolemia With Two Heterozygous Variants Including a Novel Mutation c.1800T>A in the ABCG5 Gene: A Case Report of a Rare Condition in a Young Saudi Girl.CureusPubMed ↗
  42. 2024Use and effectiveness of PCSK-9 inhibitors in heart diseases: A review.MedicinePubMed ↗
  43. 2024Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study.The lancet. Diabetes & endocrinologyPubMed ↗
  44. 2024The effectiveness of liver transplantation in reducing lipid levels in Saudi children with homozygous familial hypercholesterolemia.Frontiers in cardiovascular medicinePubMed ↗
  45. 2024Prognostic Value of Normal Triglyceride Levels among Patients with Target Low-density Lipoproteins Presenting with First Acute Coronary Syndrome.Heart views : the official journal of the Gulf Heart AssociationPubMed ↗
  46. 2023Identification and functional characterization of two rare LDLR stop gain variants (p.C231* and p.R744*) in Saudi familial hypercholesterolemia patients.Panminerva medicaPubMed ↗
  47. 2023Association of CELSR2, APOB100, ABCG5/8, LDLR, and APOE polymorphisms and their genetic risks with lipids among the Thai subjects.Saudi journal of biological sciencesPubMed ↗
  48. 2023Management and clinical outcomes of patients with homozygous familial hypercholesteremia in Saudi Arabia.Monaldi archives for chest disease = Archivio Monaldi per le malattie del toracePubMed ↗
  49. 2023Apigenin ameliorates hypercholesterolemic-induced kidney injury via modulating renal KIM-1, Fn1, and Nrf2 signaling pathways.European review for medical and pharmacological sciencesPubMed ↗
  50. 2023Various Expressions of PIK3C2A and TXNIP Genes and Their Potential Role as Independent Risk Factors for Chronic Stable Angina and Acute Coronary Syndrome.BiomoleculesPubMed ↗
  51. 2023Exploring the Sociodemographic and Behavioral Status of People Living with Hypercholesterolemia in Saudi Arabia: A Nation-Wide Cross-Sectional Study.Risk management and healthcare policyPubMed ↗
  52. 2023Protein structural insights into a rare PCSK9 gain-of-function variant (R496W) causing familial hypercholesterolemia in a Saudi family: whole exome sequencing and computational analysis.Frontiers in physiologyPubMed ↗
  53. 2023Novel LDLR Variant in Familial Hypercholesterolemia: NGS-Based Identification, In Silico Characterization, and Pharmacogenetic Insights.Life (Basel, Switzerland)PubMed ↗
  54. 2023Physicians' perceptions and beliefs on the current dyslipidemia management practices within Saudi Arabia.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical SocietyPubMed ↗
  55. 2023Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study.Cardiology and therapyPubMed ↗
  56. 2023Genetic association between vitamin D receptor gene and Saudi patients confirmed with Familial Hypercholesterolemia.Acta biochimica PolonicaPubMed ↗
  57. 2022Cost-Effectiveness Analysis of Evolocumab for the Treatment of Dyslipidemia in the Kingdom of Saudi Arabia.PharmacoEconomics - openPubMed ↗
  58. 2022Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update.AtherosclerosisPubMed ↗
  59. 2022Identification of Novel and Known LDLR Variants Triggering Severe Familial Hypercholesterolemia in Saudi Families.Current vascular pharmacologyPubMed ↗
  60. 2022Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases.Advances in therapyPubMed ↗
  61. 2022Gaps in knowledge and practice for familial hypercholesterolemia among physicians caring for children in Saudi Arabia.European review for medical and pharmacological sciencesPubMed ↗
  62. 2022Edible Bird's Nest Regulates Hepatic Cholesterol Metabolism through Transcriptional Regulation of Cholesterol Related Genes.Evidence-based complementary and alternative medicine : eCAMPubMed ↗
  63. 2022Association of cytochromes P450 3A4*22 and 3A5*3 genotypes and polymorphism with response to simvastatin in hypercholesterolemia patients.PloS onePubMed ↗
  64. 2022Identifying significant genes and functionally enriched pathways in familial hypercholesterolemia using integrated gene co-expression network analysis.Saudi journal of biological sciencesPubMed ↗
  65. 2022Ataxia with oculomotor apraxia type 1 associated with mutation in the APTX gene: A case study and literature review.Experimental and therapeutic medicinePubMed ↗
  66. 2022Lycopene Modulates Oxidative Stress and Inflammation in Hypercholesterolemic Rats.Pharmaceuticals (Basel, Switzerland)PubMed ↗
  67. 2022New Trends and Therapies for Familial Hypercholesterolemia.Journal of clinical medicinePubMed ↗
  68. 2022Exome Sequencing Revealed a Novel Splice Site Variant in the CRB2 Gene Underlying Nephrotic Syndrome.Medicina (Kaunas, Lithuania)PubMed ↗
  69. 2021Dietary Recommendations for Familial Hypercholesterolaemia: an Evidence-Free Zone.BMJ evidence-based medicinePubMed ↗
  70. 2021Coronary artery disease in patients with human immunodeficiency virus infection.Journal of nuclear cardiology : official publication of the American Society of Nuclear CardiologyPubMed ↗
  71. 2021LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway.Journal of cellular physiologyPubMed ↗
  72. 2021Late outcomes in survivors of childhood acute myeloid leukemia: a report from the St. Jude Lifetime Cohort Study.LeukemiaPubMed ↗
  73. 2021Homozygous Familial Hypercholesterolemia (HoFH) in Saudi Arabia and Two Cases of Lomitapide Use in a Real-World Setting.Advances in therapyPubMed ↗
  74. 2021Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry.PloS onePubMed ↗
  75. 2021Saudi Familial Hypercholesterolemia Patients With Rare LDLR Stop Gain Variant Showed Variable Clinical Phenotype and Resistance to Multiple Drug Regimen.Frontiers in medicinePubMed ↗
  76. 2021Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).Lancet (London, England)PubMed ↗
  77. 2020The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results.Current vascular pharmacologyPubMed ↗
  78. 2020Molecular insights into the coding region mutations of low-density lipoprotein receptor adaptor protein 1 (LDLRAP1) linked to familial hypercholesterolemia.The journal of gene medicinePubMed ↗
  79. 2020Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registry.AtherosclerosisPubMed ↗
  80. 2020Breast arterial calcification on mammography does not predict coronary artery disease by invasive coronary angiography.Annals of Saudi medicinePubMed ↗
  81. 2020Association of ANGPTL8 (Betatrophin) Gene Variants with Components of Metabolic Syndrome in Arab Adults.Scientific reportsPubMed ↗
  82. 2020Insights into pharmacological mechanisms of polydatin in targeting risk factors-mediated atherosclerosis.Life sciencesPubMed ↗
  83. 2020Assessment of medical intern's knowledge, awareness and practice of familial hypercholesterolemia at academic institutes in Jeddah, Saudi Arabia.Lipids in health and diseasePubMed ↗
  84. 2020Lomitapide for treatment of homozygous familial hypercholesterolemia: The Québec experience.AtherosclerosisPubMed ↗
  85. 2019Screening of common genetic variants in the APOB gene related to familial hypercholesterolemia in a Saudi population: A case-control study.MedicinePubMed ↗
  86. 2019Recently reported familial hypercholesterolemia-related mutations from cases in the Middle East and North Africa region.Current opinion in lipidologyPubMed ↗
  87. 2019Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia.Cardiovascular drugs and therapyPubMed ↗
  88. 2019Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.European journal of preventive cardiologyPubMed ↗
  89. 2019Modifying inter-cistronic sequence significantly enhances IRES dependent second gene expression in bicistronic vector: Construction of optimised cassette for gene therapy of familial hypercholesterolemia.Non-coding RNA researchPubMed ↗
  90. 2019Spinocerebellar ataxia with axonal neuropathy type 1 revisited.Journal of clinical neuroscience : official journal of the Neurosurgical Society of AustralasiaPubMed ↗
  91. 2019A short review of proprotein convertase subtilisin/kexin type 9 inhibitors.Reviews in cardiovascular medicinePubMed ↗
  92. 2019Genetic Risk Score for Coronary Disease Identifies Predispositions to Cardiovascular and Noncardiovascular Diseases.Journal of the American College of CardiologyPubMed ↗
  93. 2019PCSK9 and inflammation: a review of experimental and clinical evidence.European heart journal. Cardiovascular pharmacotherapyPubMed ↗
  94. 2019LDLR Gene Polymorphisms (rs5925 and rs1529729) Are Associated with Susceptibility to Coronary Artery Disease in a South Indian Population.Medical sciences (Basel, Switzerland)PubMed ↗
  95. 2019Assessment of family physicians' awareness and knowledge of familial hypercholesterolemia in governmental hospitals in Riyadh, Saudi Arabia.Journal of family medicine and primary carePubMed ↗
  96. 2019Treatment effect of alirocumab according to age group, smoking status, and hypertension: Pooled analysis from 10 randomized ODYSSEY studies.Journal of clinical lipidologyPubMed ↗
  97. 2019Familial hypercholesterolemia with bilateral cholesterol granuloma: A case series.International journal of surgery case reportsPubMed ↗
  98. 2019Molecular Dynamics Simulation Reveals Exposed Residues in the Ligand-Binding Domain of the Low-Density Lipoprotein Receptor that Interacts with Vesicular Stomatitis Virus-G Envelope.VirusesPubMed ↗
  99. 2018In Silico Approach to Investigate the Structural and Functional Attributes of Familial Hypercholesterolemia Variants Reported in the Saudi Population.Journal of computational biology : a journal of computational molecular cell biologyPubMed ↗
  100. 2018Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf.Journal of clinical lipidologyPubMed ↗